SpinaFX Earns CE Mark for Triojection Spine System
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Medical Devices, Diagnostics, Radiation-Emitting Products
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
Bloomington, Minnesota, USA | July 16, 2026 Saluda Medical announced that the U.S. Food and Drug Administration (FDA) has...
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
DURHAM, N.C., July 14, 2026 Levee Medical has reached a significant clinical development milestone with the successful completion of...
FRIENDSWOOD, Texas, July 14, 2026 Castle Biosciences, Inc. has announced that its AdvanceAD-Txâ„¢ test has received assay approval from...
SINGAPORE, July 14, 2026 The National University Hospital (NUH) has announced plans to significantly expand its use of wearable...
DENVER, July 14, 2026 SeaStar Medical announced its support for multiple educational initiatives aimed at improving the diagnosis and...
SANTA CLARA, Calif., July 14, 2026 Autonomous Healthcare has achieved a landmark regulatory milestone after the U.S. Food and...
IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...
BASEL, Switzerland, July 14, 2026 Roche has introduced the cobas® Hepatitis D Virus (HDV) test, the first fully automated,...
